Skip to content

Neonatal Pain Management and Pain Monitoring Using New Methods

Neonatal Pain Management and Pain Monitoring Using New Methods: A Randomized Controlled Trial With Crossover Design

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04967118
Enrollment
36
Registered
2021-07-19
Start date
2023-05-02
Completion date
2024-12-31
Last updated
2023-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute, Procedural Pain, Infant

Brief summary

The aim of this randomized controlled study with crossover design is to examine the effectiveness of mother-driven interventions, skin-to-skin contact (SSC) and recorded mother's heartbeats as sound and vibration (MHB), compared to oral glucose in relieving neonatal acute pain related to heel lance as a painful procedure. The effectiveness of interventions will be assessed using validated pain scales (PIPP-R and NIAPAS), changes in sensory cortex activation (near-infrared spectroscopy, NIRS) and changes in physiological indicators (oxygen saturation, heart rate, respiratory rate). The secondary objectives will include evaluating the effectiveness of interventions in relation to infant recovery and evaluating the use of NIRS monitoring in relation to neonatal pain assessment scales.

Interventions

Diaper clad baby will be placed ventral position on bare chest of mother 30 minute prior to the heel lance

BEHAVIORALMother's heartbeats as sound and vibration

The mother's heartbeat will be recorded and the heartbeat sounds will be saved to the platform. The platform will be placed under the infant's mattress and the heartbeat will be started 30 minute prior to the heel lance.

The infant will be given 30% oral glucose solution 2 minutes before the injection

Sponsors

University of Oulu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Two research assistants (NICU nurses) who are blinded to the intervention condition (30% oral glucose and combination of 30% oral glucose and the mother's heartbeat intervention) will be perform calculation of infant PIPP-R and NIAPAS scores independently. Calculating NIAPAS scores will requires observation of the neonate's body, so during the skin-to-skin contact the intervention condition cannot be blinded. NIRS signals will be analyzed by researchers who are unaware of the nature of intervention and whether they are analyzing a noxious or non-noxious stimulation. To minimize observer bias, research assistants and researchers analyzing the NIRS signal will not be permitted to attend data collection sessions and will not share datasets or communicate with each other regarding the study.

Intervention model description

A crossover design with each child as his or her own control will be used to minimize interchild variability. Order of interventions will be randomly assigned by computer-generated program.

Eligibility

Sex/Gender
ALL
Age
32 Weeks to 42 Weeks
Healthy volunteers
No

Inclusion criteria

* Gestational Age (GA) at birth 32+0 - 42+0 * Admitted to NICU * Parents are able to read, write and speak Finnish

Exclusion criteria

* With a postnatal age of 14 days or more * Apgar points were 6 or less at 5 minutes of age * Has been found grade III or IV cerebral haemorrhage * Major congenital anomalies * Has intubated or receiving a nCPAP * Has received analgesics or sedatives for less than 24 hours prior to the study

Design outcomes

Primary

MeasureTime frameDescription
Change in respiratory rateBaseline 1, measured pre-interventionNeonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in respiratory rate using bedside patient monitor.
Change in scores of Neonatal Infant Acute Pain Assessment Scale (NIAPAS)Baseline 1, measured pre-interventionPain intensity will be assessed using pain assessment tool, the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). NIAPAS is multidimensional pain assessment scale used in Finland. It consist of five behavioral indicators, three physiological indicators, and one contextual indicator.
Change in the activation in the somatosensory cortical areas following the noxious stimulation (baseline)Baseline 1, measured pre-interventionIn this study pain will be assessed measuring changes cortical hemodynamics by near-infrared spectroscopy (NIRS). A 2-channel NIRS will be used. The emitted probe provides near-infrared light through on optical fiber will be is placed slightly posterior to Cz position with reference to the international EEG 10-20 system. The receive probes will be fastened over somatosensory and occipital area. In the area of the somatosensory cortex, receive probes will be placed 2 to 4 cm from the emitted probe so that they are placed slightly behind C3 or C4 point. The occipital region receive probe will be attached 2 to 4 cm from the emitted probe.
Change in the activation in the somatosensory cortical areas following the noxious stimulationBaseline 2, measured pre-procedureIn this study pain will be assessed measuring changes cortical hemodynamics by near-infrared spectroscopy (NIRS). A 2-channel NIRS will be used. The emitted probe provides near-infrared light through on optical fiber will be is placed slightly posterior to Cz position with reference to the international EEG 10-20 system. The receive probes will be fastened over somatosensory and occipital area. In the area of the somatosensory cortex, receive probes will be placed 2 to 4 cm from the emitted probe so that they are placed slightly behind C3 or C4 point. The occipital region receive probe will be attached 2 to 4 cm from the emitted probe.
Change of the activation in the somatosensory cortical areas following the noxious stimulationMeasured during painful procedureIn this study pain will be assessed measuring changes cortical hemodynamics by near-infrared spectroscopy (NIRS). A 2-channel NIRS will be used. The emitted probe provides near-infrared light through on optical fiber will be is placed slightly posterior to Cz position with reference to the international EEG 10-20 system. The receive probes will be fastened over somatosensory and occipital area. In the area of the somatosensory cortex, receive probes will be placed 2 to 4 cm from the emitted probe so that they are placed slightly behind C3 or C4 point. The occipital region receive probe will be attached 2 to 4 cm from the emitted probe.
Change in heart rate (HR)Baseline 1, measured pre-interventionNeonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in heart rate using bedside patient monitor.
Change in oxygen saturationBaseline 1, measured pre-interventionNeonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in oxygen saturation using bedside patient monitor.
Change in scores of Premature Infant Pain profile-Revised (PIPP-R) scaleBaseline 1, measured pre-interventionPain intensity will be assessed using pain assessment tool, the Premature Infant Pain Profile Revised (PIPP-R). PIPP-R is an internationally widely used multidimensional pain assessment scale consisting of three behavioral indicators, two physiological indicators, and two contextual indicators.

Secondary

MeasureTime frameDescription
Recovery measured by change in scores of the Neonatal Infant Acute Pain Assessment Scale (NIAPAS)3 minutes after painful procedureTime to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' NIAPAS scores returns to baseline values.
Recovery as measured by changes in somatosensory cortex activation3 minutes after painful procedureTime to recovery from painful stimulus will be considered the amount of time in minutes that pass until the activation in the somatosensory cortical area measured by NIRS returns to baseline values.
Recovery as measured by changes in heart rate (HR)3 minutes after painful procedureThe physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor.
Recovery as measured by changes in oxygen saturation3 minutes after painful procedureThe physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in oxygen saturation using a patient monitor.
Recovery as measured by changes in respiratory rate3 minutes after painful procedureThe physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor.
Recovery measured by change in scores of the Premature Infant Pain profile-Revised (PIPP-R)3 minutes after painful procedureTime to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' PIPP-R scores returns to baseline values.

Countries

Finland

Contacts

Primary ContactAnna-Kaija Palomaa
annakaija.palomaa@gmail.com+358400892159

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026